A breakthrough study led by Monash University researchers has shed light on the factors shaping the intricate wiring of our brains.

About The Study: This cross-sectional study found a substantial increase in glucagon-like peptide-1 (GLP-1) per-patient days supplied in employer plans over the study period (2021-2024), with higher growth in plans that covered GLP-1s for weight loss. With increases in utilization, the estimate of differential per member per month cost for GLP-1 coverage is increasing over time and could signal higher financial burden on patients and payers in the future, though some of the added drug cost (yet unquantified) is likely offset by lower medical spending.

As people continue to live longer and the survival rate of cancer diagnoses increases, researchers from VCU Massey Comprehensive Cancer Center led a multi-decade analysis studying the rates of subsequent primary cancers (SPCs), which are new cancers unrelated to the original diagnosis. The study, which was recently published in PLOS Medicine, provides understanding for how these cancer risks change over time and across generations, helping guide future prevention and monitoring measures.

A team of Massey researchers used cancer registry data from over three million cancer survivors in the United States from 1975-2021 to study patterns of SPCs, examining age, calendar period and birth cohort effects on SPC risk.

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

JMIR Publications released three News and Perspectives stories exploring different areas of authenticity in the current clinical and scholarly landscape.